SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-056580
Filing Date
2020-12-09
Accepted
2020-12-09 17:11:52
Documents
5
Period of Report
2020-12-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tcon-8k_20201207.htm 8-K 48701
2 EX-3.1 tcon-ex31_40.htm EX-3.1 10930
3 EX-5.1 tcon-ex51_39.htm EX-5.1 14912
4 EX-99.1 tcon-ex991_6.htm EX-99.1 179241
5 GRAPHIC gcrfao4zc4l2000001.jpg GRAPHIC 28720
  Complete submission text file 0001564590-20-056580.txt   294990
Mailing Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122
Business Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122 858-550-0780
Tracon Pharmaceuticals, Inc. (Filer) CIK: 0001394319 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36818 | Film No.: 201378546
SIC: 2836 Biological Products, (No Diagnostic Substances)